Streetbeat News

Stock Prices

PFE

Recent options activity for Pfizer (NYSE:PFE) shows significant interest from big-money investors, with a mix of bullish and bearish sentiments. The majority of trades are calls, indicating a bullish outlook. Analysts have mixed ratings, with an average target price of $42.0.

Portfolio Pulse from Benzinga Insights

July 15, 2024 | 5:01 pm

ATEC

Over the past three months, 4 analysts have shared their insights on Alphatec Holdings (NASDAQ:ATEC), with ratings ranging from bullish to bearish. The average 12-month price target has decreased by 11.76% to $18.75. Analysts have adjusted their ratings and price targets, reflecting evolving market conditions and company performance.

Portfolio Pulse from Benzinga Insights

July 15, 2024 | 5:01 pm

DG

Over the past three months, 13 analysts have evaluated Dollar General (NYSE:DG), with a mix of bullish, somewhat bullish, and indifferent ratings. The average 12-month price target has decreased by 3.65% to $150.0. Analysts have adjusted their ratings and price targets in response to market conditions and company performance.

Portfolio Pulse from Benzinga Insights

July 15, 2024 | 5:00 pm

CHE

Chemed (NYSE:CHE) has significantly outperformed the market over the past 15 years, delivering an average annual return of 18.98%. A $1000 investment in CHE 15 years ago would be worth $13,515.05 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

July 15, 2024 | 5:00 pm

EA

Electronic Arts (NASDAQ:EA) has outperformed the market over the past 10 years with an average annual return of 14.18%, resulting in a $1000 investment growing to $3,765.49. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

July 15, 2024 | 5:00 pm

LEGN

In the past three months, 15 analysts have provided ratings for Legend Biotech (NASDAQ: LEGN), with the majority being bullish. The average 12-month price target has decreased slightly to $78.93. Analysts have varied in their actions, with some lowering their price targets while others maintain or raise their ratings. Legend Biotech has shown significant revenue growth but struggles with profitability and returns.

Portfolio Pulse from Benzinga Insights

July 15, 2024 | 5:00 pm

DVA

FMS

DaVita and Fresenius shares are trading lower following a report suggesting the FTC is investigating the companies.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 4:58 pm

SPY

Fed Chair Powell expressed confidence in achieving lower inflation without significant labor market pain, suggesting a 'hard landing' is unlikely. He emphasized that unemployment cannot be reduced to a single number and that maximum employment depends on various factors.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 4:58 pm

SPY

Fed Chair Powell stated that the actions taken in 2020 in response to the pandemic will be viewed positively in history. He acknowledged that there will be debates about the Fed's response to inflation.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 4:55 pm

UPST

Upstart Holdings, Inc. (NASDAQ:UPST) shares are trading higher after announcing a partnership with Texans Credit Union. The stock rose 17% last week and is up 8.82% today. The company is trending on social media and has high short interest, which can lead to large price movements.

Portfolio Pulse from Erica Kollmann

July 15, 2024 | 4:53 pm